• 4673 Citations
  • 38 h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

Dr. Jann’s research interests are in pharmacogenomics, pharmacokinetics, and pharmacodynamics of CNS and other molecules in clinical research.

Education/Academic qualification

PharmD, University of Southern California

BS in Biology, California State University Los Angeles

Fingerprint Dive into the research topics where Michael Jann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Haloperidol Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
olanzapine Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1980 2019

An elective course in lesbian, gay, bisexual, and transgender health and practice issues

Jann, M. W., Penzak, S., White, A. & Tatachar, A., 1 Jan 2019, In : American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.

Research output: Contribution to journalArticle

Transgender Persons
health care
2 Citations (Scopus)

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

Serotonin Uptake Inhibitors
Gastrointestinal Tract
Osteopathic Physicians

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access
Transgender Persons
health care
Delivery of Health Care
Antipsychotic Agents
Pharmaceutical Preparations
7 Citations (Scopus)

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Patient Education